These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17129830)

  • 41. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of mergers and acquisitions on drug discovery: perspective from a case study of a Japanese pharmaceutical company.
    Shibayama S; Tanikawa K; Fujimoto R; Kimura H
    Drug Discov Today; 2008 Jan; 13(1-2):86-93. PubMed ID: 18190869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knowledge discovery in neuroinformatics.
    Wilkowski B
    Stud Health Technol Inform; 2009; 150():589. PubMed ID: 19745379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine.
    Hou T; Wang J; Li Y
    J Chem Inf Model; 2007; 47(6):2408-15. PubMed ID: 17929911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can we rationally design promiscuous drugs?
    Hopkins AL; Mason JS; Overington JP
    Curr Opin Struct Biol; 2006 Feb; 16(1):127-36. PubMed ID: 16442279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can we estimate the accuracy of ADME-Tox predictions?
    Tetko IV; Bruneau P; Mewes HW; Rohrer DC; Poda GI
    Drug Discov Today; 2006 Aug; 11(15-16):700-7. PubMed ID: 16846797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Data visualization during the early stages of drug discovery.
    Maniyar DM; Nabney IT; Williams BS; Sewing A
    J Chem Inf Model; 2006; 46(4):1806-18. PubMed ID: 16859312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three decades of structure- and property-based molecular design.
    Müller K
    Chimia (Aarau); 2014; 68(7-8):472-82. PubMed ID: 25437386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drugs in other drugs: a new look at drugs as fragments.
    Siegel MG; Vieth M
    Drug Discov Today; 2007 Jan; 12(1-2):71-9. PubMed ID: 17198975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing drug-likeness--what are we missing?
    Vistoli G; Pedretti A; Testa B
    Drug Discov Today; 2008 Apr; 13(7-8):285-94. PubMed ID: 18405840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multi-dimensional QSAR in drug discovery.
    Lill MA
    Drug Discov Today; 2007 Dec; 12(23-24):1013-7. PubMed ID: 18061879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physicochemical drug properties associated with in vivo toxicological outcomes: a review.
    Price DA; Blagg J; Jones L; Greene N; Wager T
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):921-31. PubMed ID: 19519283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Web-based cheminformatics and molecular property prediction tools supporting drug design and development at Novartis.
    Ertl P; Mühlbacher J; Rohde B; Selzer P
    SAR QSAR Environ Res; 2003; 14(5-6):321-8. PubMed ID: 14758976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Forging synergies in drug discovery.
    Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672
    [No Abstract]   [Full Text] [Related]  

  • 56. The promise of a virtual lab in drug discovery.
    Rauwerda H; Roos M; Hertzberger BO; Breit TM
    Drug Discov Today; 2006 Mar; 11(5-6):228-36. PubMed ID: 16580600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-throughput and parallel screening methods in asymmetric hydrogenation.
    Jäkel C; Paciello R
    Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304
    [No Abstract]   [Full Text] [Related]  

  • 58. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular properties that influence oral drug-like behavior.
    Lajiness MS; Vieth M; Erickson J
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):470-7. PubMed ID: 15338956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.